006620 — DongKoo Bio & Pharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Market Cap
KR₩185bn
Enterprise Value
KR₩207bn
Revenue
KR₩216bn

Annual balance sheet for DongKoo Bio & Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	32,666	29,507	31,956	34,785	21,457
Net Total Accounts Receivable
Net Total Receivables	20,681	17,592	16,408	19,403	22,449
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	71,901	72,353	73,832	87,417	88,365
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	38,489	40,377	40,051	39,681	50,483
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	132,725	144,353	154,786	172,059	191,103
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38,345	40,508	50,022	66,044	73,318
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	47,073	49,701	54,662	69,953	80,703
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	85,652	94,653	100,124	102,106	110,400
Total Liabilities & Shareholders' Equity	132,725	144,353	154,786	172,059	191,103
Total Common Shares Outstanding